Arcadia Biosciences (RKDA) Receivables - Net (2014 - 2025)

Arcadia Biosciences' Receivables - Net history runs 12 years deep, the most recent figure standing at $425000.0 for Q4 2025.

• Quarterly Receivables - Net fell 63.83% year-over-year to $425000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $425000.0 (down 63.83% YoY) and the FY2025 annual result came in at $425000.0, down 63.83% from the prior year.
• Receivables - Net was $425000.0 for Q4 2025 at Arcadia Biosciences, down from $831000.0 in the prior quarter.
• Across five years, Receivables - Net topped out at $3.9 million in Q2 2022 and bottomed at $304000.0 in Q3 2023.
• A 5-year average of $1.3 million and a median of $1.1 million in 2021 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2021 — Receivables - Net jumped 289.54% — and 2023, when it plunged 88.85%.
• Arcadia Biosciences' Receivables - Net stood at $1.4 million in 2021, then decreased by 12.41% to $1.2 million in 2022, then sank by 57.83% to $506000.0 in 2023, then surged by 132.21% to $1.2 million in 2024, then sank by 63.83% to $425000.0 in 2025.
• Business Quant data shows RKDA's Receivables - Net at $425000.0 in Q4 2025, $831000.0 in Q3 2025, and $1.3 million in Q2 2025.